Subventions et aides pour les organisations sociales

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

États-Unis · US

Qui peut postuler Special district governments · City or township governments · Independent school districts · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Small businesses · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · County governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized)

This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

États-Unis · US

Qui peut postuler Small businesses · For profit organizations other than small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · City or township governments · Native American tribal organizations (other than Federally recognized tribal governments) · Public housing authorities/Indian housing authorities · County governments · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized)

This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a significant improvement in the translational relevance of animal models or ex vivo systems that will be utilized to facilitate future development of neurotherapeutics. Ideally, models proposed for this FOA would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Program focused on enabling the exploratory and early stages of drug discovery.

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

États-Unis · US

Qui peut postuler Private institutions of higher education · Public and State controlled institutions of higher education

The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for health professional, undergraduate and graduate students and enhancing the research environment at applicant institutions.Eligible institutions must award baccalaureate or advanced science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the schools and colleges within the institution as a whole.Help determining the Organization Funding Level can be found here or https://grants.nih.gov/grants/funding/r15.htmThis REAP Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For purposes of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

États-Unis · US

Qui peut postuler Public and State controlled institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Native American tribal governments (Federally recognized) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · County governments · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · Special district governments · State governments · Small businesses · City or township governments

Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA supports a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach. Projects seeking support for a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies should consider the companion U01 FOA.

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

États-Unis · US

Qui peut postuler Public housing authorities/Indian housing authorities · Native American tribal organizations (other than Federally recognized tribal governments) · For profit organizations other than small businesses · Special district governments · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · City or township governments · County governments · State governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · Private institutions of higher education · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education

Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This NOFO using the U01 mechanism supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies Projects seeking support for a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach should consider the companion U19 FOA.

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

États-Unis · US

Qui peut postuler Others (see text field entitled "Additional Information on Eligibility" for clarification) · Independent school districts · State governments · Private institutions of higher education · Public and State controlled institutions of higher education · City or township governments · Special district governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · County governments · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses

The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

États-Unis · US

Qui peut postuler Small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Private institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · County governments · Native American tribal organizations (other than Federally recognized tribal governments) · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · For profit organizations other than small businesses · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

bases que rexerán o procedemento de concesión de axudas a entidades privadas para o fomento da gratuidade da atención educativa dos nenos e nenas da Comunidade Autónoma de Galicia en escolas infantís 0-3 para o curso 2026/2027 e se procede á súa convocato

AUTONOMICA - GALICIA - CONSELLERÍA DE POLÍTICA SOCIAL E IGUALDAD ·

Educación

Période : 28/7/2026 – —

Labelliser les projets susceptibles de bénéficier du FEDER au titre du soutien à la biodiversité et à la lutte contre les inondations sur le Bassin de la Seine

France · FR

Qui peut postuler Commune · Intercommunalité / Pays · Département · Etablissement public dont services de l'Etat · Entreprise publique locale (Sem, Spl, SemOp)

Le présent appel à projets, lancé par la Direction régionale et interdépartementale de l'environnement, de l'aménagement et des transports (DRIEAT), vise à labelliser les projets susceptibles de bénéficier du FEDER au titre du soutien à la biodiversité et à la lutte contre les inondations sur le Bassin de la Seine, dans le cadre du Programme régional 2021-2027. L’enveloppe consacrée à la thématique des continuités écologiques est de 3,5 millions d'euros. LES OBJECTIFS DE L'APPEL À PROJETS Le présent appel à projets vise à susciter et présélectionner des opérations contribuant à la restauration de la continuité écologique des cours d'eau afin de reconquérir les axes migratoires. Les opérations correspondront aux objectifs suivants : Améliorer la continuité des cours d'eau afin de permettre aux poissons migrateurs d'élargir leur aire de répartition Assurer le suivi des populations et le développement des connaissances sur les différentes espèces Restaurer les populations des poissons migrateurs amphialins du bassin de la Seine et des côtiers Normands

Période : 5/6/2024 – —

Labelliser les projets susceptibles de bénéficier du FEDER au titre du soutien à la biodiversité et à la lutte contre les inondations sur le Bassin de la Seine

France · FR

Qui peut postuler Commune · Département · Etablissement public dont services de l'Etat

Le présent appel à projets, lancé par la DRIEAT, vise à labelliser les projets susceptibles de bénéficier du FEDER au titre du soutien à la biodiversité et à la lutte contre les inondations sur le Bassin de la Seine, dans le cadre du Programme régional 2021-2027. L’enveloppe portant sur les inondations est de 5,5 millions d’euros. LES OBJECTIFS DE L'APPEL À PROJETS Le présent appel à projets vise à susciter et présélectionner des opérations répondant à au moins l’un des 3 grands objectifs du Plan de gestion des risques d'inondations du bassin Seine-Normandie, à savoir : Aménager les territoires de manière résiliente de manière à réduire leur vulnérabilité ; Agir sur l’aléa pour augmenter la sécurité des personnes et réduire le coût des dommages ; Mobiliser tous les acteurs au service de la connaissance et de la culture du risque.

Période : 5/6/2024 – —

Open topic on research and innovation for effective management of EU external borders that promotes fundamental rights and EU values

Union européenne · EU

Open topic on research and innovation for effective management of EU external borders that promotes fundamental rights and EU values

Période : 5/5/2027 – —

Trusted, secure, quality future digital travel credentials

Union européenne · EU

Trusted, secure, quality future digital travel credentials

Période : 5/5/2027 – —

Detection and characterisation of threats or illegal/ smuggled goods in cargo

Union européenne · EU

Detection and characterisation of threats or illegal/ smuggled goods in cargo

Période : 5/5/2027 – —

Open Topic on advanced protective gear optimized for CBRN-E (Chemical, Biological, Radiological, Nuclear, Explosives) environments and new generation of smart protective equipment for disaster responders

Union européenne · EU

Open Topic on advanced protective gear optimized for CBRN-E (Chemical, Biological, Radiological, Nuclear, Explosives) environments and new generation of smart protective equipment for disaster responders

Période : 5/5/2027 – —

Societal resilience, engagement of the younger generations and digital innovation for disaster resilience

Union européenne · EU

Societal resilience, engagement of the younger generations and digital innovation for disaster resilience

Période : 5/5/2027 – —

Enhancing decision support system for disaster crises: leveraging emerging technologies for improved civil preparedness and crisis management

Union européenne · EU

Enhancing decision support system for disaster crises: leveraging emerging technologies for improved civil preparedness and crisis management

Période : 5/5/2027 – —

Enhancing preparedness for large-scale cross-border disasters

Union européenne · EU

Enhancing preparedness for large-scale cross-border disasters

Période : 5/5/2027 – —

Online harms detection and investigation tools using a short development cycle model

Union européenne · EU

Online harms detection and investigation tools using a short development cycle model

Période : 5/5/2027 – —

Community policing in diverse societies in Europe

Union européenne · EU

Community policing in diverse societies in Europe

Période : 5/5/2027 – —

Open topic on enhanced prevention, detection and deterrence of societal issues related to various forms of crime

Union européenne · EU

Open topic on enhanced prevention, detection and deterrence of societal issues related to various forms of crime

Période : 5/5/2027 – —

Open topic on increasing security of citizens against terrorism, including in public spaces

Union européenne · EU

Open topic on increasing security of citizens against terrorism, including in public spaces

Période : 5/5/2027 – —

Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe

Union européenne · EU

Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe

Période : 5/5/2027 – —

Enhancing physical protection of critical infrastructures

Union européenne · EU

Enhancing physical protection of critical infrastructures

Période : 5/5/2027 – —

Impact of malicious use of Open-Source Intelligence on critical infrastructure business continuity

Union européenne · EU

Impact of malicious use of Open-Source Intelligence on critical infrastructure business continuity

Période : 5/5/2027 – —